Skip Navigation


Europace Advance Access originally published online on November 13, 2008
Europace 2009 11(2):158-163; doi:10.1093/europace/eun309
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
11/2/158    most recent
eun309v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Europace
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Letsas, K. P.
Right arrow Articles by Arentz, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Letsas, K. P.
Right arrow Articles by Arentz, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org


Ablation for Atrial Fibrillation

Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation

Konstantinos P. Letsas*, Reinhold Weber, Gerd Bürkle, Constantinos C. Mihas, Jan Minners, Dietrich Kalusche and Thomas Arentz

Arrhythmia Service, Herz-Zentrum, Südring 15, 79189 Bad Krozingen, Germany

Aims: An increasing body of evidence has demonstrated the essential role of inflammation in the genesis and maintenance of atrial fibrillation (AF). The aim of the present study was to investigate whether success or failure of electrical pulmonary vein isolation (PVI) in patients with AF is related with the presence of a pre-ablative inflammatory state as determined by known clinical parameters and conventional markers of inflammation including high-sensitivity C-reactive protein, white blood cell (WBC) count, and fibrinogen.

Methods and results: Seventy-two patients with paroxysmal (64%) or persistent AF (36%) underwent successful electrical PVI. The mean duration of arrhythmia was 5.5 ± 2.9 years. After a mean follow-up period of 12.5 ± 5.7 months, 44 patients (61%) were in sinus rhythm. In univariate Cox proportional hazard regression analysis, hypertension, body mass index (BMI), left ventricular ejection fraction, left ventricular end-diastolic diameter, left atrial diameter (LAD), WBC count, and high-sensitivity C-reactive protein were significantly associated with AF recurrence (P < 0.05). In multivariate Cox proportional hazard regression analysis, hypertension [hazard ratio (HR) 3.127; 95% confidence interval (CI) 1.269–7.706, P = 0.013], LAD (HR 1.077; 95% CI 1.014–1.144, P = 0.015), and WBC count (HR 1.423; 95% CI 1.067–1.897, P = 0.016) were independent pre-ablative predictors of AF recurrence following PVI.

Conclusion: Conventional markers of the inflammatory cascade such as WBC count and high-sensitivity C-reactive protein as well as elements of the metabolic syndrome such as hypertension and increased BMI were significantly associated with AF recurrence. The impact of a pre-ablative inflammatory state in the overall success rate of PVI needs further elucidation.

Key Words: Atrial fibrillation, Ablation, Recurrence, Inflammation, Obesity


* Corresponding author. Fax: +49 76334022429, Email: k.letsas{at}mail.gr

Manuscript submitted 21 August 2008. Accepted after revision 20 October 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in Europace:

Is inflammation a risk factor for recurrent atrial fibrillation?
Marcelle D. Smit and Isabelle C. Van Gelder
Europace 2009 11: 138-139. [Full Text]  

Does inflammation influence atrial fibrillation recurrence following catheter ablation?
Antonios Kourliouros and A. John Camm
Europace 2009 11: 135-137. [Full Text]  



This article has been cited by other articles:


Home page
EuropaceHome page
M. D. Smit and I. C. Van Gelder
Is inflammation a risk factor for recurrent atrial fibrillation?
Europace, February 1, 2009; 11(2): 138 - 139.
[Full Text] [PDF]


Home page
EuropaceHome page
A. Kourliouros and A. J. Camm
Does inflammation influence atrial fibrillation recurrence following catheter ablation?
Europace, February 1, 2009; 11(2): 135 - 137.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.